Hormone therapy and platelet function

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 1, 2005, Pages 85-91

  Leng, Xing Hong ^a   Bray, Paul F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CONJUGATED ESTROGEN; D DIMER; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; FIBRINOGEN; GESTAGEN; HORMONE RECEPTOR; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROTEIN C; PROTEIN S; PROTHROMBIN; SEX HORMONE; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ESTROGEN BLOOD LEVEL; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEMOSTASIS; HORMONAL THERAPY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; POSTMENOPAUSE; PREGNANCY; REVIEW; SEX DIFFERENCE; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; VEIN THROMBOSIS; VISCOSITY;

EID: 33645090935     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.05.028     Document Type: Review

References (46)

1. D. Grady et. al. Hormone therapy to prevent disease and prolong life in postmenopausal women Ann. Intern. Med. 117 1992 1016-1037
2. S. Hulley et. al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group J. Am. Med. Assoc. 280 1998 605-613
3. J.E. Rossouw et. al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial J. Am. Med. Assoc. 288 2002 321-333
4. G.L. Anderson et. al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial J. Am. Med. Assoc. 291 2004 1701-1712
5. D.J. Fitzgerald et. al. Platelet activation in unstable coronary disease N. Engl. J. Med. 315 1986 983-989
6. M.H. Kroll et. al. Platelets and shear stress Blood 88 1996 1525-1541
7. M. Johnson et. al. Sex and age differences in human platelet aggregation Nature 253 1975 355-357
8. N. Faraday et. al. Gender differences in platelet GPIIb-IIIa activation Thromb. Haemost. 77 1997 748-754
9. K. Kurrelmeyer et. al. Platelet hyperreactivity in women from families with premature atherosclerosis J. Am. Med. Woman Assoc. 85 2003 272-277
10. X.H. Leng et. al. Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males Arterioscler. Thromb. Vasc. Biol. 24 2004 376-381
11. Y. Nagata et. al. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol Genes Dev. 17 2003 2864-2869
12. L. Moro et. al. Nongenomic effects of 17beta-estradiol in human platelets: Potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase Blood 105 2005 115-121
13. M.D. Tarantino et. al. The estrogen receptor is present in human megakaryocytes Ann. N.Y. Acad. Sci. 714 1994 293-296
14. S.B. Jones et. al. α 2-Adrenergic receptor binding in human platelets: Alterations during the menstrual cycle Clin. Pharmacol. Ther. 34 1983 90-96
15. J.R. Sheu et. al. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways Clin. Lab. Haematol. 24 2002 121-129
16. M.H. Tong et. al. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice Nat. Med. 11 2005 153-159
17. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet (1997) 349, 1202-1209.
18. A.E. Schorer et. al. Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis Prostaglandins Med. 1 1978 5-11
19. M.L. Bierenbaum et. al. Increased platelet aggregation and decreased high-density lipoprotein cholesterol in women on oral contraceptives Am. J. Obstet. Gynecol. 134 1979 638-641
20. N.K. Shevde J.W. Pike Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis Blood 87 1996 2683-2692
21. S. Bord et. al. Megakaryocyte population in human bone marrow increases with estrogen treatment: A role in bone remodeling? Bone 27 2000 397-401
22. D. Feng et. al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study Arterioscler. Thromb. Vasc. Biol. 19 1999 1142-1147
23. M.B. Elam et. al. Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbit Prostaglandins 20 1980 1039-1051
24. H. Kuhl Pharmacokinetics of oestrogens and progestogens Maturitas 12 1990 171-197
25. F. Stossi et. al. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: Distinct and common target genes for these receptors Endocrinology 145 2004 3473-3486
26. J.G. Wilcox et. al. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein Fertil. Steril. 67 1997 57-62
27. B.R. Bhavnani Estrogens and menopause: Pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's J. Steroid Biochem. Mol. Biol. 85 2003 473-482
28. T. Thomas et. al. Progestins initiate adverse events of menopausal estrogen therapy Climacteric 6 2003 293-301
29. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000 Fertil. Steril. 75 2001 898-915
30. G.M. Dores et. al. Platelet adhesion at low shear rate: Study of a normal population Thromb. Res. 69 1993 173-184
31. F.P. Chen et. al. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women Fertil. Steril. 69 1998 267-273
32. M.E. Miller et. al. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions Thromb. Res. 74 1994 577-594
33. T. Simoncini et. al. Genomic and non-genomic effects of estrogens on endothelial cells Steroids 69 2004 537-542
34. C.M. Revankar et. al. A transmembrane intracellular estrogen receptor mediates rapid cell signalling Science 307 2005 1625-1630
35. G. Khetawat et. al. Human megakaryocytes and platelets contain the estrogen receptor b and androgen receptor (AR): Testosterone regulates AR expression Blood 95 2000 2289-2296
36. M.L. Nealen et. al. Human platelets contain a glycosylated estrogen receptor beta Circ. Res. 88 2001 438-442
37. I. Poola V. Speirs Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues J. Steroid Biochem. Mol. Biol. 78 2001 459-469
38. I. Poola et. al. Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: Alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha FEBS Lett. 516 2002 133-138
39. J. Bar et. al. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17b-estradiol and medroxyprogesterone acetate in postmenopausal women Thromb. Haemost. 84 2000 695-700
40. Y. Nakano et. al. Effect of 17b-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis Arterioscler. Thromb. Vasc. Biol. 18 1998 961-967
41. B.B. Raman et. al. Effects of estradiol and progesterone on platelet calcium responses Am. J. Hypertens. 8 1995 197-200
42. R. Tepper et. al. The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women Maturitas 24 1996 51-56
43. J.B. Braunstein et. al. Interaction of hemostatic genetics with hormone therapy: New insights to explain arterial thrombosis in postmenopausal women Chest 121 2002 906-920
44. K.D. Boudoulas et. al. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation Arch. Pathol. Lab. Med. 125 2001 112-115
45. P.F. Bray et. al. Genetic variations in platelet glycoproteins Iba and VI interact with hormone therapy to modify the risk for coronary heart disease events in postmenopausal women Blood 104 2004 (Abstract)
46. A.L. Hersh et. al. National use of postmenopausal hormone therapy: annual trends and response to recent evidence J. Am. Med. Assoc. 291 2004 47-53